My work focuses on the development of targeted mRNA-based therapy for the treatment of kidney fibrosis in chronic kidney disease (CKD). I work with urine-derived stem cells (USCs) and investigate how nanoparticle-based delivery systems can enhance the therapeutic potential of these cells. The research is preclinical and includes both cell culture and animal models, aiming to promote local tissue repair in the kidney.